• Title/Summary/Keyword: Dopamine neuron

검색결과 34건 처리시간 0.025초

Cholecystokinin에 의한 음식물 섭취 억제시 흰쥐 뇌내 Dopamine 함량에 대한 면역조직화학 및 생화학적 연구 (Immunohistochemical and Biochemical Studies on Dopamine Content in Rat Brain During Cholecystokinin-Induced Suppression of Feeding)

  • 정주호;김양제;임성빈;박승준;고계창;정지창
    • 대한약리학회지
    • /
    • 제30권1호
    • /
    • pp.39-48
    • /
    • 1994
  • 포만중추 (satiety center)를 자극하여 음식섭취를 억제한다고 알려진 CCK-8을 흰쥐 복강에 투여하여, 흰쥐 뇌의 도파민 변화에 대한 CCK-8의 효과를 관찰하였다. 흰쥐 뇌의 부위별 도파민 함량은 HPLC-ECD방법으로 측정하였으며, 시상하부와 흑질에서의 TH-immunoreactive neuron은 면역조직화학법과 영상분석법을 시행하였다. 굶긴 쥐에서는 정상 쥐에 비하여, 도파민 함량이 전두 피질, 해마, 시상하부 및 편도체에서 각각 감소하였다. CCK-8을 투여한 쥐는 정상 쥐와 굶긴 쥐에 비하여, 도파민 함량이 시상하부에서 의미있게 감소하였다. 또한 굶긴 쥐는 정상 쥐와 비교하여, TH-positive neuron의 분포와 수가 뇌실옆핵, 깔때기핵, 정중융기 및 혹질에서 현저히 감소하였다. CCK-8투여시, 시상하부와 흑질에서의 TH-immunoreactive neuron의 수는 굶긴 쥐에 비하여 증가하였다. 이상의 실험 결과로 보아 음식물 섭취를 억제하는 작용이 있는 CCK-8은 시상하부의 도파민 신경계와 일부분 관련되어 있으며, 또한 시상하부와 흑질에 존재하는 TH-positive neuron은 음식물 섭취 행위에 중요한 역할이 있음을 시사하고 있다.

  • PDF

표준화된 인삼추출물 G115의 중추도파민신경계에 대한 신경화학적 연구(II) (Neurochemical Studies of Standardized Ginseng Extract G115 on the Central Dopaminergic Activity (II))

  • 이순철;유관희;김용호
    • Journal of Ginseng Research
    • /
    • 제16권3호
    • /
    • pp.183-189
    • /
    • 1992
  • Effect of the standardized ginseng extract(G115) on the central monoaminergic systems were investigated in comparison with that of halcperidol in rats. Immediately after sacrificed by decapitation, the strlata and frontal cortex were removerl. Concentations of the monoamines dopamine and serctorLin and their metabolites were deterinintd by HPLC-EC. G115 increased the concentration of 5-HIAA and DOPAC/UA ratio in striatum. However, dopaminrrgic neuronal activities were not affected by G115 that decreased the concentratio,Is of 5-HT and 5-HIAA in frontal cortex. G115 in combination with apomorphine significantly irlcreased the concentration of DA and S-HT but decreased the DO PAC/DA ratio and 5-HIAA/5-HT ratio only in frontal cortex. These results suggest that G115 like HPD inhibits the activity of nigrostriatal dopamine neuron in striatum. However, unlike HPD it activates central monoaminergic neuron activity in frontal cortex.

  • PDF

신경성장촉진 인자가 인간 배아줄기세포 유래 도파민 분비 신경세포형성에 미치는 영향 (Effects of Neurotrophic Factors on the Generation of Functional Dopamine Secretory Neurons Derived from in vitro Differentiated Human Embryonic Stem Cells)

  • 이금실;김은영;신현아;조황윤;왕규창;김용식;이훈택;정길생;이원돈;박세필;임진호
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제31권1호
    • /
    • pp.19-27
    • /
    • 2004
  • Objective: This study was to examine the in vitro neural cell differentiation patterns of human embryonic stem (hES) cells following treatment of various neurotrophic factors [basic fibroblast growth factor (bFGF), retinoic acid (RA), brain derived neurotrophic factor (BDNF) and transforming growth factor (TGF)-$\alpha$], particulary in dopaminergic neuron formation. Methods: The hES cells were induced to differentiate by bFGF and RA. Group I) In bFGF induction method, embryoid bodies (EBs, for 4 days) derived from hES were plated onto gelatin dish, selected for 8 days in ITSFn medium and expanded at the presence of bFGF (10 ng/ml) for another 6 days followed by a final differentiation in N2 medium for 7, 14 and 21 days. Group II) For RA induction, EBs were exposed of RA ($10^{-6}M$) for 4 days and allowed to differentiate in N2 medium for 7, 14 and 21 days. Group III) To examine the effects of additional neurotrophic factors, bFGF or RA induced cells were exposed to either BDNF (10 ng/ml) or TGF-$\alpha$ (10 ng/ml) during the 21 days of final differentiation. Neuron differentiation and dopamine secretion were examined by indirect immunocytochemistry and HPLC, respectively. Results: The bFGF or RA treated hES cells were resulted in similar neural cell differentiation patterns at the terminal differentiation stage, specifically, 75% neurons and 11% glial cells. Additionally, treatment of hES cells with BDNF or TGF-$\alpha$ during the terminal differentiation stage led to significantly increased tyrosine hydroxylase (TH) expression of a dopaminergic neuron marker, compared to control (p<0.05). In contrast, no effect was observed on the rate of mature neuron (NF-200) or glutamic acid decarboxylase-positive neurons. Immunocytochemistry and HPLC analyses revealed the higher levels of TH expression (20.3%) and dopamine secretion (265.5 $\pm$ 62.8 pmol/mg) in bFGF and TGF-sequentially treated hES cells than those in $\alpha$ RA or BDNF treated hES cells. Conclusion: These results indicate that the generation of dopamine secretory neurons from in vitro differentiated hES cells can be improved by TGF-$\alpha$ addition in the bFGF induction protocol.

도파민 발현 세포주 CV(bDAT) 세포에서 항정신병 약물이 도파민 수송체 활성에 미치는 영향 (Effect of Antipsychotic Drugs on Dopamine Transporter Function in CV(bDAT) Cells)

  • 김영미;이용성;이상훈;오동렬;양병환;조석신;남정현
    • 생물정신의학
    • /
    • 제4권1호
    • /
    • pp.48-53
    • /
    • 1997
  • CV(bDAT) cell line, expressing dopamine transporter stably, has been established by transfection of CV-1 cells with bovine dopamine transporter cDNA. Using CV(bDAT) cells, the effects of various antipsychotic drugs on dopamine uptake activity were investigated. All of antipsychotic drugs tested, inhibited the [$^3H$]dopamine uptake into CV(bDAT) cells with $IC_{50}s$ in the low to mid micromolar range, implying that antipsychotic drugs may produce overflow of dopamine in the synaptic cleft of dopaminergic neuron.

  • PDF

하지불안증후군이 중추신경계 질환임을 시사하는 임상적, 신경영상학적, 신경생리학적 증거들에 관하여 (Clinical, Neuroimaging and Neurophysiologic Evidences of Restless Legs Syndrome as a Disorder of Central Nervous System)

  • 정기영
    • Annals of Clinical Neurophysiology
    • /
    • 제10권2호
    • /
    • pp.98-100
    • /
    • 2008
  • Restless legs syndrome (RLS) is a sensorimotor neurological disorder in which the primary symptom is a compelling urge to move the legs, accompanied by unpleasant and disturbing sensations in the legs. Although pathophysiologic mechanism of RLS is still unclear, several evidences suggest that RLS is related to dysfunction in central nervous system involving brain and spinal cord. L-DOPA, as the precursor of dopamine, as well as dopamine agonists, plays an essential role in the treatment of RLS leading to the assumption of a key role of dopamine function in the pathophysiology of RLS. Patients with RLS have lower levels of dopamine in the substantia nigra and respond to iron administration. Iron, as a cofactor in dopamine production, plays a central role in the etiology of RLS. Functional neuroimaging studies using PET and SPECT support a central striatal D2 receptor abnormality in the pathophysiology of RLS. Functional MRI suggested a central generator of periodic limb movements during sleep (PLMs) in RLS. However, to date, we have no direct evidence of pathogenic mechanisms of RLS.

  • PDF

단일 도파민뉴런을 이용한 새로운 유전자발현 검출기법 (The Novel Approach of Gene Detection by Single-neuronal Cell Manipulation)

  • 정상민
    • KSBB Journal
    • /
    • 제20권4호
    • /
    • pp.323-327
    • /
    • 2005
  • 조직을 이용한 역전사 (RT)-PCR법을 이용하면 원하는 특정유전자의 발현을 비교적 정확하게 알 수 있지만 조직의 RNA를 이용하므로 세포단위의 정확한 유전자 발현을 알기에는 한계가 있다. 특히 그 기능과 성질이 다른 세포가 무수하게 많이 혼재하는 두뇌와 같은 조직은 신경계의 각종 뉴런(신경세포), 글리어 (glial cell) 등이 서로 얽혀 있다. 대표적인 신경세포의 degeneration 질병으로는 파킨슨병 (Parkinson's disease; PD)이 있다. 파킨슨병은 사람의 신경세포 관련 질병에 있어서 가장 일반적인 질병의 하나이다. PD의 가장 중요한 원인은 도파민 생성 신경세포의 퇴행 혹은 사멸에 기인하여 도파민 (dopamine)이라는 신경전달물질이 감소하는 것이 그 원인이다. 도파민과 같은 카테콜아민의 생합성에 관련된 효소는 타이로신 하이드록실레이스 (TH), 도파 데카르복실레이스 (DDC) 등이 알려져 있다. 그러나 그런 효소들의 생화학적 연구는 많이 되어 있음에도 불구하고 단일 흑질 신경세포에서의 이들 관련 유전자의 발현 양상에 대해서는 알려진 바가 거의 없다. PD와 관련된 유전자의 발현 정도를 밝히기 위하여, 레이저 다이섹터 (laser micro-dissector)에 의한 단일 신경세포의 분리에 착수하였다. 정해진 방법에 따라 정상 대조구 (비PD)와 PD 환자에서 각각 한 개 또는 여러 개를 성공적으로 분리한 흑질 신경세포를 이용하여 유전자 특이적 프라이머를 사용하여 RT-PCR을 행하였다. 그 결과, 단 한 개의 신경세포에서도 여러 개의 세포를 사용한 것과 같은 동일한 결과를 얻는 데 성공하였다. PD환자의 뇌에서 분리한 10개의 독립적인 세포의 예에서는 각 세포간의 발현차이가 인정되었으며, 특히 TH 유전자의 발현은 상당히 높은 확률로 검출되지 않았다. 이 결과로 단일 신경세포에서의 mRNA양을 검출하기 위해서는 본 본문의 RT-PCR법이 효과적인 방법임을 알 수 있다.

Effect of Dopamine on a Voltage-Gated Potassium Channel in a Jellyfish Motor Neuron

  • Chung, Jun-Mo;Spencer, Andrew N.
    • BMB Reports
    • /
    • 제29권2호
    • /
    • pp.151-155
    • /
    • 1996
  • To swimming motor neurons (SMNs) of Polyorchis penicillatus, a hydrozoan medusae, dopamine (DA) acts as an inhibitory neurotransmitter by hyperpolarizing its membrane potential and decreasing its firing rate as well. Such an inhibitory action of DA is caused by an increased permeability to potassium (K) ions. To investigate whether voltage-gated K channels are directly responsible for the membrane hyperpolarization induced by DA, we employed whole-cell voltage clamp configuration. One ${\mu}M$ DA applied to SMNs increased the peak and rear values of voltage-gated K currents by 37 and 54%, respectively, in a reversible manner. Combined with subtraction analysis, this result suggests that the outflux of K ions by DA in SMNs occurs mainly through rectifier-like K channels.

  • PDF

로봇을 위한 인공 두뇌 개발 (Artificial Brain for Robots)

  • 이규빈;권동수
    • 로봇학회논문지
    • /
    • 제1권2호
    • /
    • pp.163-171
    • /
    • 2006
  • This paper introduces the research progress on the artificial brain in the Telerobotics and Control Laboratory at KAIST. This series of studies is based on the assumption that it will be possible to develop an artificial intelligence by copying the mechanisms of the animal brain. Two important brain mechanisms are considered: spike-timing dependent plasticity and dopaminergic plasticity. Each mechanism is implemented in two coding paradigms: spike-codes and rate-codes. Spike-timing dependent plasticity is essential for self-organization in the brain. Dopamine neurons deliver reward signals and modify the synaptic efficacies in order to maximize the predicted reward. This paper addresses how artificial intelligence can emerge by the synergy between self-organization and reinforcement learning. For implementation issues, the rate codes of the brain mechanisms are developed to calculate the neuron dynamics efficiently.

  • PDF

황납추출물이 도파민세포 보호효과 및 파킨슨병 행동장애에 미치는 영향 (Cera Flava Improves Behavioral and Dopaminergic Neuronal Activities in a Mouse Model of Parkinson's Disease)

  • 임혜선;문병철;박건혁
    • 한국환경과학회지
    • /
    • 제31권5호
    • /
    • pp.423-429
    • /
    • 2022
  • Parkinson's Disease (PD) is a chronic neurodegenerative disorder caused by the progressive loss of dopaminergic neurons, leading to decreased dopamine levels in the midbrain. Although the specific etiology of PD is not yet known, oxidative stress, inflammation, and subsequent apoptosis have been proposed to be closely related to PD pathophysiology. Cera Flava (CF) is a natural extract obtained from beehives and is isolated through the heating, compression, filtration, and purification of beehives. CF has been used in traditional medicines for its various clinical and pharmacological effects. However, its effects on neurodegenerative diseases are unknown. Therefore, we investigated the effects of CF against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD in mice and explored the underlying mechanism of action. In MPTP-induced PC12 cells, CF protected NADH dehydrogenase activity and inhibited lactate dehydrogenase. In the mouse model, CF promoted recovery from movement impairments, prevented dopamine depletion, and protected against MPTP-induced dopaminergic neuronal degradation. Moreover, CF downregulated glial and microglial activation. Taken together, our results suggest that CF improves behavioral impairments and protects against dopamine depletion in MPTP-induced toxicity by inhibiting glial and microglial activation.

특발성 파킨슨병.파킨슨증후군 환자 7례의 치료경과사례 고찰 (A Research on 7 Cases of the Treatment Process for Patients with Idiopathic Parkinson's Disease or Parkinsonism)

  • 박병준
    • 동의신경정신과학회지
    • /
    • 제20권3호
    • /
    • pp.283-295
    • /
    • 2009
  • Objectives : Parkinson's disease is a chronic neuron-degenerative disease. The medication of dopamine, one of the most common treatment for the disease, has effects of improving the symptom, but when taken for a long term, the medicine brings about side-effects such as the phenomenon of medicinal efficacy disappearance and dyskinesia. In addition, it doesn't have any effects in slowing down or stopping the development of Parkinson's disease. Methods : Accordingly, this study aims to investigate the clinical cases to stop or improve the development of Parkinson's disease by carrying out an independent treatment with Oriental medicine and a combined treatment with Western and Oriental medicines respectively for over 6 months. Results and Conclusions : The results of the study is expected to be an important precedent for the treatment of neuron-degenerative diseases of cranial nerve including Parkinson's disease in the future.

  • PDF